Viewing StudyNCT00113347



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00113347
Status: COMPLETED
Last Update Posted: 2012-02-27
First Post: 2005-06-07

Brief Title: Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy XRT for Head and Neck Squamous Cell Carcinoma HNSCC
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Head and Neck Cancer
Keywords:
Name View
Concomitant Boost Radiation View
Head and Neck Cancer View
Squamous Cell Carcinoma View
Erlotinib View
Docetaxel View
Radiation View
Radiotherapy View